Skip to main content
. 2014 Jun 25;307(4):F427–F434. doi: 10.1152/ajprenal.00072.2014

Fig. 3.

Fig. 3.

A: adding 10−5 mol/l cycloheximide to the CNT perfusate did not prevent the sensitization of CTGF by aldosterone, suggesting that the effect of aldosterone on CTGF is not genomic. **P < 0.01; ***P < 0.001, control vs. aldosterone plus cycloheximide. B: cycloheximide alone did not affect CTGF in the absence of exogenous aldosterone.